Medico Remedies Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Harshit Mehta
Chief executive officer
₹4.9m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 13yrs |
| CEO ownership | 0.8% |
| Management average tenure | 7.3yrs |
| Board average tenure | 7.3yrs |
Recent management updates
Recent updates
Investors Appear Satisfied With Medico Remedies Limited's (NSE:MEDICO) Prospects As Shares Rocket 27%
Nov 12
Medico Remedies Limited's (NSE:MEDICO) P/E Is Still On The Mark Following 25% Share Price Bounce
Sep 21Medico Remedies Limited (NSE:MEDICO) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
Mar 22Here's Why We Think Medico Remedies (NSE:MEDICO) Is Well Worth Watching
Jun 22What You Can Learn From Medico Remedies Limited's (NSE:MEDICO) P/E After Its 27% Share Price Crash
Jun 26Estimating The Fair Value Of Medico Remedies Limited (NSE:MEDICO)
Jun 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹77m |
| Jun 30 2024 | n/a | n/a | ₹85m |
| Mar 31 2024 | ₹5m | ₹5m | ₹83m |
| Dec 31 2023 | n/a | n/a | ₹70m |
| Sep 30 2023 | n/a | n/a | ₹78m |
| Jun 30 2023 | n/a | n/a | ₹82m |
| Mar 31 2023 | ₹5m | ₹5m | ₹72m |
| Dec 31 2022 | n/a | n/a | ₹75m |
| Sep 30 2022 | n/a | n/a | ₹63m |
| Jun 30 2022 | n/a | n/a | ₹51m |
| Mar 31 2022 | ₹5m | ₹5m | ₹48m |
| Dec 31 2021 | n/a | n/a | ₹33m |
| Sep 30 2021 | n/a | n/a | ₹28m |
| Jun 30 2021 | n/a | n/a | ₹19m |
| Mar 31 2021 | ₹3m | ₹3m | ₹26m |
| Dec 31 2020 | n/a | n/a | ₹25m |
| Sep 30 2020 | n/a | n/a | ₹25m |
| Jun 30 2020 | n/a | n/a | ₹20m |
| Mar 31 2020 | ₹2m | ₹2m | ₹16m |
| Dec 31 2019 | n/a | n/a | ₹18m |
| Sep 30 2019 | n/a | n/a | ₹19m |
| Jun 30 2019 | n/a | n/a | ₹17m |
| Mar 31 2019 | ₹2m | ₹2m | ₹16m |
Compensation vs Market: Harshit's total compensation ($USD57.36K) is above average for companies of similar size in the Indian market ($USD42.22K).
Compensation vs Earnings: Harshit's compensation has been consistent with company performance over the past year.
CEO
Harshit Mehta (39 yo)
13yrs
Tenure
₹4,905,000
Compensation
Mr. Harshit Haresh Mehta has been Managing Director of Medico Remedies Limited since September 15, 2017 and serves its Marketing and Export head. He serves as Whole time Director Medico Remedies Limited. H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 30.8yrs | ₹5.89m | 20.76% ₹ 989.3m | |
| MD, Marketing & Export Head and Director | 13yrs | ₹4.91m | 0.80% ₹ 38.3m | |
| Production of Technical & Quality Control Head and Whole-Time Director | 9.8yrs | ₹4.91m | 12.65% ₹ 602.9m | |
| Chief Accountant | no data | no data | no data | |
| Company Secretary & Compliance Officer | less than a year | no data | no data | |
| Executive Director | less than a year | no data | no data | |
| Head of the Production Department - General | no data | no data | no data | |
| Head of Production Department (B-Lactum) | no data | no data | no data |
7.3yrs
Average Tenure
47yo
Average Age
Experienced Management: MEDICO's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 30.8yrs | ₹5.89m | 20.76% ₹ 989.3m | |
| MD, Marketing & Export Head and Director | 13yrs | ₹4.91m | 0.80% ₹ 38.3m | |
| Production of Technical & Quality Control Head and Whole-Time Director | 9.8yrs | ₹4.91m | 12.65% ₹ 602.9m | |
| Executive Director | less than a year | no data | no data | |
| Women Non-Executive Director | 25yrs | no data | 8.23% ₹ 392.1m | |
| Non-Executive Independent Director | 7.3yrs | ₹6.00k | no data | |
| Non-Executive Independent Director | 7.3yrs | ₹6.00k | no data | |
| Non-Executive Independent Director | 2.7yrs | ₹6.00k | 0.0042% ₹ 201.1k | |
| Independent Director | less than a year | no data | no data |
7.3yrs
Average Tenure
59.5yo
Average Age
Experienced Board: MEDICO's board of directors are considered experienced (7.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 11:02 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medico Remedies Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|